Nirsevimab — Drug Intelligence | 3 EU Trials

Filter these 3 trials by condition, phase, country and more.

3 Registered trials

1 Recruiting

1 Completed trials

3 Sponsors

3 Countries

Phase III

Phase IV

Phase III: 2 Phase IV: 1

Indications tested

3 total

Pregnancy and Infant PrEparedness pLatform IN Europe (PIPELINE)-RSV immunisation adaptive platform trial (PIPELINE-RSV) Pending

2025-522194-11-00 Phase III 2 countries Fondazione Penta Ets
PIPELINE-RSV-France Recruiting

2025-521755-23-00 Phase III 1 country Centre Hospitalier Annecy Genevois
Implementation RSV Immunization Study (IRIS) Ended

2025-521801-42-00 Phase IV 1 country Rijksinstituut voor Volksgezondheid en Milieu (RIVM)

Showing 1–3 of 3 trials